Innovation in funding models and public-private investment is needed to accelerate the systemic changes required to improve women’s health outcomes and ensure social and economic equity for everyone.
Our Action
Amplify51 action is aligned with the Australian Government’s Department of Health (2019) National Women’s Health Strategy 2020–2030.
Increase awareness of the investment opportunity in women’s health.
01
Educate investors and policymakers on the commercial case for investing in the health of women by highlighting data on market growth, revenue models and return on investment potential, with successful case studies to demonstrate the economic opportunity.
Mobilise early and growth-stage capital.
02
Connect strategic institutions, philanthropic organisations and impact investors to support innovative women’s health startups and expand access to essential services such as early diagnostics and preventative care.
Leverage national and international collaboration.
03
Through shared data and aligned regulatory and policy reviews, build investment in data platforms, clinical trial networks, and regulatory and reimbursement approval pathways to ensure solutions are investable, scalable, and reach patients without undue delay.